Table 4.
Serum concentrations of ADAM10, ADAM12, ADAM17, and ADAM28 in both groups.
| Clinical staging | ADAM10 (ng/ml) | ADAM12 (ng/ml) | ADAM17 (ng/ml) | ADAM28 (ng/ml) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Min | Max | Mean | Min | Max | Mean | Min | Max | Mean | Min | Max | Mean | |
| CSI | 1.7 | 260.7 | 140.9 | 0.6 | 26.7 | 5.4 | 0.65 | 9.8 | 2.4 | 244.8 | 1226.3 | 774.8 |
| CSII | 9.9 | 270.7 | 104.3 | 0.8 | 20.7 | 3.4 | 0.4 | 15.5 | 1.5 | 21.8 | 1545.8 | 835.0 |
| CSIII | 20.5 | 256.3 | 101.4 | 1.9 | 16.4 | 4.52 | 0.9 | 7.6 | 1.8 | 17.1 | 1251.8 | 619.4 |
| CSIV | 79.4 | 321.8 | 111.9 | 2.6 | 15.8 | 5.69 | 0.8 | 3.8 | 2.33 | 479.6 | 1422.3 | 1019.7 |
| Control group | 0.03 | 1.14 | 0.32 | 0.26 | 3.81 | 1.99 | 0.71 | 5.25 | 2.78 | 1.67 | 14.36 | 3.72 |